Inimmune Corporation and Intrommune Therapeutics, Inc have announced a collaboration to advance a clinical-stage oral mucosal therapy for those individuals with food allergies. The combination of treatments used by both companies could be a game changer for patients suffering from peanut allergies.
Click here to read the press release.